Skip to main content
OpenTrials
Completed

NCT Number: NCT02604576

Efficacy of Bromopride and Simethicone Versus Bromopride in Functional Dyspepsia

Multi-center, randomized, superiority, double blind clinical trial to asses the efficacy of fixed-dose combination of bromopride and simethicone versus isolated bromopride on research participants diagnosed with functional dyspepsia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Centro de Medicina Reprodutiva Carlos Isaia Filho Ltda, Porto Alegre, Rio Grande do Sul, Brazil

Loading trial locations.

About this study

Multi-center, randomized, superiority, double blind clinical trial to asses the efficacy of fixed-dose combination of bromopride and simethicone versus isolated bromopride in the relief os dyspepsia symptoms on research participants diagnosed with functional dyspepsia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed Informed Consent;
  • Participants aged 18- 70 years;
  • Clinical diagnosis of functional dyspepsia according to Rome III criteria;
  • Minimum score of 22 points in PADYQ questionnaire

Exclusion criteria

  • Diagnosis of gastroesophageal reflux disease, irritable bowel syndrome, inflammatory bowel disease, gallstones, strongyloidiasis, giardiasis or ascariasis, clinical disease or significant psychological;
  • Positive diagnosis for Helicobacter pylori;
  • Clinically significant organic diseases in the HDE (High Digestive Endoscopy) prior to randomization;
  • History of esophageal surgery, gastrointestinal or other intra-abdominal surgery;
  • Hypersensitivity to the components of the formulations;
  • Allergy tartrazine yellow dye;
  • Allergy to aspirin;
  • Use of PPIs, H2 blockers, prokinetics, antibiotics, prostaglandins or bismuth salts in the last week before the screening visit;
  • Use of NSAIDs or aspirin more than two days a week (except AAS <325mg / day), other drugs that induce gastrointestinal symptoms;
  • Pregnant women or women without adequate contraception;
  • Advance Participation in clinical trial protocols in the last twelve (12) months (CNS Resolution 251 of August 7, 1997, Part III, subsection J), unless the investigator considers that there may be direct benefit to it;
  • Changes in hematological and biochemical tests: hemoglobin less than 12 g / dl, results with value 2 times the reference for AST, ALT, Gamma GT and alkaline phosphatase;
  • Diagnosis of neurological or psychiatric diseases or decompensated diabetes;
  • Use of drugs with anticholinergic action, narcotic analgesics, sedatives, hypnotics or tranquilizers;
  • Alcoholism or sporadic use of alcohol and illicit drug use.

Treatment and study plan

FDC Bromopride 10 mg and Simethicone 80 mg

Drug

Fixed-dose combination of Bromopride 10 mg and Simethicone 80 mg

Other names: Bromopride 10 mg and Simethicone 80 mg

Bromopride 10 mg

Drug

Bromopride 10 mg

Other names: Digesan®

Primary outcomes

  1. Symptoms assessed by proportion of participants who have reduction equal to or greater than 50% in symptoms through questionnaire PADYQ

    Time frame: 4 weeks

Secondary outcomes

  1. Adverse events

    Time frame: 4 weeks

    Safety assessment will be performed by evaluating the incidence of adverse events in each group as well as the relationship of these events to the drug used, the amount and severity of reported events.

Sponsors and collaborators

Lead sponsor

EMS

Industry

Registry information

Official study title

Efficacy of Fixed-dose Combination of Bromopride and Simethicone Versus Isolated Bromopride in Participants With Functional Dyspepsia.

Important dates

Study start
2017
Primary completion
2018
Study completion
2019
First posted
Nov 13, 2015
Registry last updated
Feb 24, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.